Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

被引：0

作者：

Pinnix, Chelsea C. ^{[1
]}

Dabaja, Bouthaina S. ^{[2
]}

Gunther, Jillian R. ^{[2
]}

Fang, Penny ^{[2
]}

Wu, Susan ^{[2
]}

Nastoupil, Loretta ^{[3
]}

Strati, Paolo ^{[3
]}

Nair, Ranjit ^{[4
]}

Ahmed, Sairah ^{[5
]}

Steiner, Raphael E. ^{[6
]}

Malpica-Castillo, Luis ^{[7
]}

Chihara, Dai ^{[8
]}

Jain, Preetesh ^{[9
]}

Fayad, Luis ^{[10
]}

Westin, Jason R. ^{[11
]}

Neelapu, Sattva S. ^{[3
]}

Rodriguez, Maria Alma ^{[5
]}

Hagemeister, Fredrick B. ^{[10
]}

Lee, Hun Ju ^{[3
]}

Wang, Michael ^{[12
]}

Samaniego, Felipe ^{[3
]}

Fowler, Nathan H. ^{[13
]}

Flowers, Christopher R. ^{[6
]}

Feng, Lei ^{[14
]}

Chi, Linda ^{[13
]}

Esmaeli, Bita

机构：

[1] MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[4] MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA

[5] MD Anderson Canc Ctr, Houston, TX USA

[6] MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[8] Univ New Mexico, Hlth Sci Ctr, Dept Leukemia, Albuquerque, NM 87131 USA

[9] UTMDACC, Dept Lymphoma & Myeloma, Houston, TX USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[11] MD Anderson, Dept Lymphoma & Myeloma, Houston, TX USA

[12] UT MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[14] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-154172

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3526

引用

页数：7

共 50 条

[1] Response Adapted Ultra Low Dose Radiation Therapy for the Definitive Management of Orbital Indolent B-Cell Lymphoma
Pinnix, C. C.
Dabaja, B.
Gunther, J. R.
Fang, P.
Wu, S. Y.
Nastoupil, L.
Strati, P.
Nair, R.
Ahmed, S.
Steiner, R.
Westin, J.
Neelapu, S. S.
Rodriguez, M. A.
Lee, H.
Wang, M. L.
Fowler, N.
Flowers, C.
Feng, L.
Chi, L.
Esmaeli, B.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S2 - S3
[2] Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma A Phase 2 Nonrandomized Controlled Trial
Pinnix, Chelsea C.
Dabaja, Bouthaina S.
Gunther, Jillian R.
Fang, Penny Q.
Wu, Susan Y.
Nastoupil, Loretta J.
Strati, Paolo
Nair, Ranjit
Ahmed, Sairah
Steiner, Raphael
Westin, Jason
Neelapu, Sattva
Rodriguez, Maria A.
Lee, Hun Ju
Wang, Michael
Flowers, Christopher
Feng, Lei
Esmaeli, Bita
[J]. JAMA ONCOLOGY, 2024,
[3] Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa
Pinnix, C. C.
Esmaeli, B.
Smith, G. L.
Milgrom, S. A.
Reed, V. K.
Arzu, I. Y.
Shank, J. H.
Horace, P.
Allen, K. S.
Turner, S. E.
Morrell, G. G.
Fowler, N.
Dabaja, B.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E459 - E459
[4] Ultra-low dose radiation therapy for primary cutaneous indolent B-cell lymphomas
Kasera, Shalini
Weil, Christopher R.
Wada, David
Bowling, Marianne
Hu, Boyu
Gaffney, David K.
Maity, Amit
Tao, Randa
[J]. JEADV CLINICAL PRACTICE, 2024, 3 (04): : 1190 - 1194
[5] Ofatumumab As Initial Therapy For Indolent B Cell Lymphomas: A Phase II Trial
Barnes, Jeffrey A.
Feng, Yang
Hochberg, Ephraim P.
Takvorian, Tak
Weitzman, James
Fisher, David C.
Jacobsen, Eric D.
Joyce, Robin
Neuberg, Donna S.
Abramson, Jeremy S.
[J]. BLOOD, 2013, 122 (21)
[6] Success of Ultra-low Dose Radiation Therapy for Primary Cutaneous B-cell Lymphoma
Onyewadume, Louisa
McClelland III, Shearwood
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (09): : 431 - 433
[7] Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Gunther, Jillian R.
Xu, Jie
Bhutani, Manoop S.
Strati, Paolo
Fang, Penny Q.
Wu, Susan Y.
Dabaja, Bouthaina S.
Dong, Wenli
Bhosale, Priya R.
Flowers, Christopher R.
Nair, Ranjit
Castillo, Luis Malpica
Fayad, Luis
Iyer, Swaminathan P.
Parmer, Simrit
Wang, Michael
Lee, Hun Ju
Samaniego, Felipe
Westin, Jason
Ahmed, Sairah
Nze, Chijioke C.
Jain, Preetesh
Neelapu, Sattva S.
Rodriguez, Maria A.
Chihara, Dai
Nastoupil, Loretta J.
Pinnix, Chelsea
[J]. LANCET HAEMATOLOGY, 2024, 11 (07): : e521 - e529
[8] Increased Dose Rituximab Followed by Maintenance Rituximab As Initial Therapy for Indolent B Cell Lymphomas: A Phase II Trial
Barnes, Jeffrey A.
Stevenson, Kristen
Hochberg, Ephraim P.
Takvorian, Tak
Fisher, David C.
LaCasce, Ann
Brown, Jennifer R.
Mahindra, Anuj K.
Neuberg, Donna
Abramson, Jeremy S.
[J]. BLOOD, 2011, 118 (21) : 1587 - 1588
[9] Low Dose Versus High Dose Radiation Therapy for Indolent Primary Cutaneous B-Cell Lymphomas
Goyal, A.
Carter, J.
Pashtan, I. M.
Gallotto, S.
Niemierko, A.
Ng, A. K.
Winkfield, K. M.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E455 - E455
[10] Interim Analysis Results of a Phase 2 Trial of Low-Dose Radiation Therapy for Palliation of Diffuse Large B-Cell Lymphoma
Furlan, C.
Bulian, P.
Spina, M.
Michieli, M.
Ermacora, A.
Tirelli, U.
Trovo, M.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S80 - S80

← 1 2 3 4 5 →